Clinical trial
Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures
NCT00326612 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00326612 |
|---|---|
| Title | Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures |
| Official title | Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy |
| Lead sponsor | University of Utah, Other |
| Collaborators | Primary Children's Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Seizures |
| Intervention type | Drug |
| Interventions | Midazolam, Diazepam |
| Enrollment | 358 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 17, 2006 |
| Last update posted | Oct 26, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: